Use of Ramucirumab for Patients with Squamous or Nonsquamous Lung Cancer

1 Views
administrator
administrator
07/07/23

In this segment, Mark Socinski, MD, discusses how the approval of ramucirumab as second- and third-line therapy has advanced the treatment of metastatic lung cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next